High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyRichard A. Nash, Daniel E. Furst, Theodore A. Gooley et al.|Blood|2007Cited by 264
Autologous Hematopoietic Stem Cell Transplantation May Be Highly Effective Treatment for Severe, Treatment Refractory Stiff Person Syndrome (S31.007)George E. Georges, Richard A. Nash, Peter A. McSweeney et al.|Neurology|2018Cited by 4
Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).Richard A. Nash, Daniel E. Furst, Peter A. McSweeney et al.|Blood|2006Cited by 0